Article
CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.
Human mutation - 1 Dec 2003
Schaeffeler Elke, Schwab Matthias, Eichelbaum Michel, Zanger Ulrich M
Abstract excerpt
The genetic polymorphism of the cytochrome P450 monooxygenase, CYP2D6, comprises at least 43 alleles giving rise to distinct drug metabolism phenotypes termed ultrarapid, extensive, intermediate, and poor metabolizers. As a consequence, drug side effects or lack of drug effect may occur if standard doses are applied. Genetic prediction of drug oxidation phenotype as a basis for dose selection requires analysis of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
